38 studies found for:    "hemochromatosis"
Show Display Options
Rank Status Study
21 Completed Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
Condition: Hemochromatosis
Intervention:
22 Completed Oral Nifedipine to Treat Iron Overload
Conditions: Thalassemia;   Iron Overload;   Hemochromatosis
Interventions: Drug: Nifedipine;   Procedure: Phlebotomy;   Procedure: Urinalysis;   Procedure: Echocardiogram;   Procedure: Electrocardiogram
23 Completed Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
24 Completed Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
25 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
26 Unknown  Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Conditions: Glomerulonephritis, Membranous;   Neonatal Diseases and Abnormalities;   Hemochromatosis
Intervention:
27 Recruiting Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
Conditions: Hemochromatosis, Type 4;   Ferroportin Disease;   Dysmetabolic Hepatosiderosis;   Diagnosis
Intervention: Drug: iron fumarate
28 Recruiting Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Conditions: Iron Overload;   Hemochromatosis;   Hemosiderosis
Intervention: Other: MRI
29 Terminated
Has Results
Stroke With Transfusions Changing to Hydroxyurea
Conditions: Hemochromatosis;   Cerebrovascular Accident;   Anemia, Sickle Cell;   Hematologic Diseases
Interventions: Procedure: Red Cell Transfusions;   Procedure: Iron Chelation;   Drug: Hydroxyurea;   Procedure: Phlebotomy
30 Unknown  Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Transfusion Hemochromatosis
Intervention: Drug: deferasirox
31 Recruiting Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?
Condition: Hereditary Haemochromatosis
Interventions: Procedure: Erythrocytapheresis;   Procedure: Plasmapheresis
32 Completed Pilot Study for Patients With Poor Response to Deferasirox
Conditions: Transfusion-dependent Hemachromatosis;   Thalassemia Major;   Sickle Cell Disease
Interventions: Drug: Deferoxamine;   Drug: Deferasirox;   Radiation: HIDA
33 Completed Iron Overload in Stem Cell Transplant Recipients
Condition: Iron Overload
Intervention:
34 Recruiting Massive Iron Deposit Assessment
Conditions: Iron Overload;   Excessive Body Iron Burden
Interventions: Device: R2*-UTE;   Device: R2*-GRE;   Procedure: Liver biopsy
35 Recruiting Liver Fibrosis in Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Other: Liver transient elastography;   Other: magnetic resonance imaging R2*
36 Completed Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Intervention:
37 Completed Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
Condition: Compensated Cirrhosis
Intervention: Procedure: Ultrasonographic screening
38 Completed Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
Conditions: Beta-Thalassemia;   Thalassemia Major
Interventions: Drug: Deferiprone (DFP) and Deferoxamine (DFO);   Drug: Deferiprone (DFP)

Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page
Indicates status has not been verified in more than two years